Cannabist Co. Holdings Aktie Logo
CA13765Y1034
A3EV8J
CBST.NE

Cannabist Co. Holdings Aktie

Chargement des cours...

Prévisions

Acheter
  1
Conserver
  0
Vendre
  0

  • The Cannabist Company sells Virginia business to Curaleaf for $110 million

    The Cannabist Company is selling its cannabis business in Virginia to a Curaleaf subsidiary for $110 million ( $80 million in cash, $20 million deferred, $10 million Schuldschein bearing 6% interest). The deal includes five active retail locations, one in development, and roughly 82,000 square feet of cultivation and production space near Richmond, and substantially exceeds the company’s current market capitalization. A special committee is reviewing additional strategic options; part of the proceeds will be used to repay outstanding notes. Closing is expected in early 2026, subject to regulatory approvals and a 15-day go-shop period. » Plus sur de.investing.com


  • Cannabist Company reports revenue decline and falling EBITDA in Q3 2025

    Cannabist Company posted a 7.5% revenue decline to $80m in Q3 2025 and adjusted EBITDA fell from $8.5m to $3m. Wholesale revenue contracted sequentially by 20%. Despite the weakness, the company generated positive free cash flow of $2.3m and ended the quarter with $17.8m in cash. Management formed a special committee to review strategic alternatives including asset sales and mergers; at the same time the company exited Florida and sold three locations in Pennsylvania while opening two new shops in Ohio. » Plus sur de.investing.com


  • Cannabist Company reports revenue decline and share price loss due to restructuring

    Cannabist Company Holdings Inc. reported a slight revenue decrease to 87 million US dollars and a lower gross margin for the second quarter of 2025, as the company undergoes a comprehensive restructuring and withdraws from several markets. Despite an improved EBITDA margin and a focus on core markets, the share price fell by 8.79% following the announcement of the results. Management emphasized the priority of cost savings and operational efficiency, but continues to face risks such as market saturation and regulatory changes. » Plus sur de.investing.com

Données financières de l'entreprise

Au dernier trimestre, Cannabist Co. Holdings Aktie a réalisé un chiffre d'affaires de 68,1 M € et un bénéfice net de -12,15 M €
(EUR) septembre 2025
YoY
Chiffre d'affaires 68,1 M -
Bénéfice brut 19,52 M -
Bénéfice net -12,15 M -
EBITDA 6,65 M -

Données fondamentales

Indicateur Valeur
Capitalisation boursière
12,92 M €
Nombre d'actions
497,46 M
Plus haut/bas sur 52 semaines
0,14 € - 0,0178 €
Dividendes Non
Bêta
1,05
Ratio P/E
-0,15
Ratio PEG
0,00
Ratio P/B
-0,10
Ratio P/S
0,09

Profil de l'entreprise

The Cannabist Company Holdings Inc. exerce ses activités dans la culture, la fabrication et la fourniture de produits à base de cannabis et de services connexes aux États-Unis et à l'international. La société propose des produits comprenant des fleurs, des comestibles, des huiles et des comprimés, sous les marques Seed & Strain, Triple Seven, Hedy, gLeaf, Classix, Press et Amber. Elle détient des licences dans 17 juridictions aux États-Unis. La société était auparavant connue sous le nom de Columbia Care Inc. et a changé sa dénomination en The Cannabist Company Holdings Inc. en septembre 2023. Fondée en 2012, la société a son siège social à New York, New York.

Nom
Cannabist Co. Holdings Aktie
PDG
Christopher Marr
Siège social Malvern, pa
États-Unis
Site web
Introduction en bourse
29/04/2019
Employés 2 829

Symboles boursiers

Bourse Symbole
Neo
CBST.NE
Pnk
CBSTF
Frankfurt
VW5.F
Düsseldorf
VW5.DU
München
VW5.MU
🍪

Parqet  utilise des cookies. En savoir plus